DITURI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 982
EU - Europa 138
AS - Asia 75
Totale 1.195
Nazione #
US - Stati Uniti d'America 982
CN - Cina 55
SE - Svezia 51
IT - Italia 26
DE - Germania 19
BE - Belgio 15
GB - Regno Unito 12
FI - Finlandia 7
IN - India 7
JP - Giappone 6
VN - Vietnam 3
FR - Francia 2
SG - Singapore 2
AL - Albania 1
DK - Danimarca 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
NL - Olanda 1
PH - Filippine 1
RS - Serbia 1
Totale 1.195
Città #
Fairfield 144
Woodbridge 138
Chandler 114
Ashburn 112
Seattle 66
Houston 60
Cambridge 57
Ann Arbor 56
Wilmington 54
Nyköping 45
Beijing 20
Brussels 15
Bari 13
Nanjing 13
Lawrence 12
Roxbury 12
San Diego 8
Inglewood 7
New York 6
Redwood City 6
Tokyo 6
Brooklyn 5
Des Moines 5
Jiaxing 5
Washington 5
Dearborn 4
Falls Church 4
Tianjin 4
Dong Ket 3
Jacksonville 3
London 3
Boardman 2
Coimbatore 2
Grafing 2
Hebei 2
Jinan 2
Nanchang 2
Nürnberg 2
Ostuni 2
Princeton 2
Singapore 2
Torricella 2
Belgrade 1
Brindisi 1
Budapest 1
Copenhagen 1
Dublin 1
Esslingen am Neckar 1
Groningen 1
Hangzhou 1
Helsinki 1
Hounslow 1
Kunming 1
Lanzhou 1
Lequile 1
Los Angeles 1
Manila 1
Miami 1
Mumbai 1
Norwalk 1
Paris 1
Phoenix 1
Prescot 1
Pune 1
San Francisco 1
San Jose 1
San Mateo 1
Shanghai 1
Shenyang 1
Tappahannock 1
Tel Aviv 1
Tirana 1
Totale 1.057
Nome #
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 124
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 115
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 110
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 91
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 88
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 87
null 86
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 84
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 82
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 77
null 75
null 70
Valutazione della percezione del rischio biologico in un gruppo di operatori di igiene dentale in formazione e di ruolo 57
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 31
Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma 27
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 25
Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma 2
Totale 1.231
Categoria #
all - tutte 4.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020387 41 20 16 43 39 32 38 47 51 24 18 18
2020/2021201 7 20 9 18 11 24 17 20 11 27 13 24
2021/2022111 4 2 2 7 7 14 2 14 10 6 16 27
2022/2023237 28 41 22 29 20 27 2 28 28 1 8 3
2023/2024113 4 14 6 17 13 26 24 2 2 2 1 2
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.231